S&P 500
(-0.87%) 5 027.40 points
Dow Jones
(-1.27%) 37 971 points
Nasdaq
(-1.28%) 15 512 points
Oil
(-0.30%) $82.56
Gas
(-0.18%) $1.650
Gold
(0.00%) $2 338.50
Silver
(-0.06%) $27.33
Platinum
(0.32%) $918.75
USD/EUR
(-0.19%) $0.933
USD/NOK
(0.05%) $10.99
USD/GBP
(-0.28%) $0.800
USD/RUB
(-0.09%) $92.24

Realtime updates for Fusion Antibodies PLC [FAB.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated25 Apr 2024 @ 11:10

0.00% £ 3.75

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:10):

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally...

Stats
Today's Volume 295 253
Average Volume 1.22M
Market Cap 3.58M
EPS £0 ( 2023-12-07 )
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -0.420
ATR14 £0.100 (2.86%)

Fusion Antibodies PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fusion Antibodies PLC Financials

Annual 2022
Revenue: £2.90M
Gross Profit: £202 000 (6.96 %)
EPS: £-0.0998
Q2 2023
Revenue: £541 000
Gross Profit: £-209 000 (-38.63 %)
EPS: £-0.0292
Q4 2022
Revenue: £1.04M
Gross Profit: £-157 000 (-15.13 %)
EPS: £-0.0569
Q3 2022
Revenue: £519 000
Gross Profit: £-16 500.00 (-3.18 %)
EPS: £-0.0284

Financial Reports:

No articles found.

Fusion Antibodies PLC

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. It offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. The company serves pharmaceutical, biotech, and diagnostic companies. It has a collaboration partnership with Celonic AG. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators